Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Yemaachi Biotechnology
company
About
Yemaachi Biotechnology provides diversifying precision cancer diagnostics and treatments.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $3M
- Industries
- Artificial Intelligence,Bioinformatics,Biotechnology,Health Diagnostics
- Founded date
- Jan 1, 2020
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$3.42M
Yemaachi Biotechnology has raised a total of
$3.42M
in funding over 2 rounds. Their latest funding was raised on
Mar 21, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 21, 2022 | Seed | $3M | 1 | — | — | Detail |
| Aug 31, 2021 | Pre-seed | $425K | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
1
Yemaachi Biotechnology has made 1 investments. Their most recent investment was on
Sep 11, 2021, when Apillon raised $3.60M.
Investors
Number of Lead Investors
Number of Investors
—
2
Yemaachi Biotechnology is funded by 2 investors.
V Square Capital
and First circle capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Seed |
|
|
— | Pre-seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
